Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dentin and root canal hard tissue surfaces constitute the primary mineralized structure of the tooth, forming the walls of the pulp chamber and the root canal system. This tissue is composed of approximately 70% inorganic hydroxyapatite, 20% organic material (predominantly Type I collagen), and 10% water (Goldberg et al., 2011). While not a traditional molecular target such as a receptor or enzyme, these surfaces are the central focus of endodontic therapy, where they must be cleaned, disinfected, and shaped to facilitate successful obturation. In the presence of disease, such as apical periodontitis, these surfaces harbor bacterial biofilms and are often covered by a smear layer of organic and inorganic debris (Zehnder, 2006). Therapeutic agents like sodium hypochlorite and EDTA are applied to these surfaces to dissolve necrotic tissue and remove the smear layer, respectively, ensuring the elimination of pathogens and improving the seal of restorative materials (Haapasalo et al., 2014). The structural integrity of these surfaces is critical for the tooth's longevity, as excessive chemical or mechanical degradation can lead to increased brittleness and fracture risk (Diogenes et al., 2016).
The therapeutic approach involves the chemical debridement of the organic collagen matrix and biofilm by proteolytic agents (e.g., sodium hypochlorite) and the chelation of calcium ions from the inorganic hydroxyapatite by chelating agents (e.g., EDTA) to remove the smear layer and open dentinal tubules for disinfection (Zehnder, 2006; Haapasalo et al., 2014).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin and root canal hard tissue surfaces.